ITOLIZUMAB NOT TO BE USED FOR TREATMENT

NEW DELHI: The National Task Force on COVID-19 has decided against including Itolizumab drug in clinical management protocols for treating the disease even though the DCGI has approved its “restricted emergency use” in infected patients, officials familiar with the matter said.